DK0625899T3 - Liposom-itraconazolformuleringer - Google Patents

Liposom-itraconazolformuleringer

Info

Publication number
DK0625899T3
DK0625899T3 DK93917397.7T DK93917397T DK0625899T3 DK 0625899 T3 DK0625899 T3 DK 0625899T3 DK 93917397 T DK93917397 T DK 93917397T DK 0625899 T3 DK0625899 T3 DK 0625899T3
Authority
DK
Denmark
Prior art keywords
liposomal
itraconazole
itraconazole formulations
phospholipid
formulations
Prior art date
Application number
DK93917397.7T
Other languages
English (en)
Inventor
Giovanni Lucchetti
Giuseppe Assogna
Pietro Bagnato
Original Assignee
Janssen Cilag S P A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Cilag S P A filed Critical Janssen Cilag S P A
Application granted granted Critical
Publication of DK0625899T3 publication Critical patent/DK0625899T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1277Preparation processes; Proliposomes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DK93917397.7T 1992-02-12 1993-02-04 Liposom-itraconazolformuleringer DK0625899T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP92200397 1992-02-12
PCT/EP1993/000273 WO1993015719A1 (en) 1992-02-12 1993-02-04 Liposomal itraconazole formulations

Publications (1)

Publication Number Publication Date
DK0625899T3 true DK0625899T3 (da) 1996-06-17

Family

ID=8210419

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93917397.7T DK0625899T3 (da) 1992-02-12 1993-02-04 Liposom-itraconazolformuleringer

Country Status (17)

Country Link
EP (1) EP0625899B1 (da)
JP (1) JPH07503953A (da)
KR (1) KR940703651A (da)
CN (1) CN1076614A (da)
AT (1) ATE138561T1 (da)
AU (1) AU661754B2 (da)
CA (1) CA2129828A1 (da)
DE (1) DE69302897T2 (da)
DK (1) DK0625899T3 (da)
ES (1) ES2091019T3 (da)
GR (1) GR3020695T3 (da)
IL (1) IL104689A (da)
MX (1) MX9300708A (da)
MY (1) MY131524A (da)
TW (1) TW267103B (da)
WO (1) WO1993015719A1 (da)
ZA (1) ZA93955B (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW438601B (en) * 1994-05-18 2001-06-07 Janssen Pharmaceutica Nv New mucoadhesive emulsion compositions and a process for the preparation thereof
DE69808670T2 (de) 1997-12-31 2003-07-03 Choongwae Pharma Corp., Seoul/Soul Herstellungsverfahren und zusammensetzung einer oralen zubereitung von itraconazol
CN1156461C (zh) 1999-03-24 2004-07-07 R·P·希拉技术股份有限公司 改良的水溶性药物制剂
KR100331529B1 (ko) * 1999-06-16 2002-04-06 민경윤 난용성 항진균제의 경구투여용 조성물 및 그의 제조 방법
KR100388605B1 (ko) * 2000-06-13 2003-06-25 코오롱제약주식회사 용해도 및 용해속도가 향상된 이트라코나졸의 액상 조성물 및 이를 이용한 이트라코나졸 제제와 그 제조방법
GB0015239D0 (en) * 2000-06-21 2000-08-16 Biochemie Gmbh Organic compounds
CU23175A1 (es) * 2000-07-17 2006-09-22 Ct De Investigacion Y Desarrol Formulacion liposomica de propionato de clobetasol
US6932861B2 (en) 2000-11-28 2005-08-23 Fmc Corporation Edible PGA coating composition
WO2004108114A2 (en) * 2003-03-31 2004-12-16 Dinesh Shantilal Patel Anti-fungal composition and a process for its manufacture
KR100712734B1 (ko) 2005-05-31 2007-05-04 에이엔에이치 케어연구소(주) 이트라코나졸을 함유하는 피부외용제
KR100970911B1 (ko) * 2007-12-13 2010-07-20 재단법인서울대학교산학협력재단 트리아졸계 항진균제를 함유하는 반고형 외용제 및 이의 제조방법
US20090175810A1 (en) 2008-01-03 2009-07-09 Gareth Winckle Compositions and methods for treating diseases of the nail
WO2009088959A1 (en) * 2008-01-04 2009-07-16 Brian Charles Keller Enhanced delivery of antifungal agents
US8039494B1 (en) 2010-07-08 2011-10-18 Dow Pharmaceutical Sciences, Inc. Compositions and methods for treating diseases of the nail
MY179756A (en) 2013-10-03 2020-11-12 Dow Pharmaceutical Sciences Stabilized efinaconazole formulations
EP3071295A4 (en) * 2013-11-22 2017-05-31 Dow Pharmaceutical Sciences, Inc. Anti-infective methods, compositions, and devices
EP3669191A4 (en) * 2017-08-20 2021-04-14 University of Connecticut NITROGEN-TYPE COMPOUND ANALOGUES AND THEIR METHODS OF USE
WO2021030174A1 (en) 2019-08-09 2021-02-18 University Of Connecticut Truncated itraconazole analogues and methods of use thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3532562A1 (de) * 1985-09-12 1987-03-12 Dolorgiet Gmbh & Co Kg Transdermal resorbierbare, wasserhaltige zubereitungen von arylpropionsaeurederivaten und verfahren zur herstellung derselben
DE3600947A1 (de) * 1986-01-15 1987-07-16 Kali Chemie Pharma Gmbh Antimykotische emulsionen
AU598002B2 (en) * 1986-07-15 1990-06-14 Cilag Ltd. Method of preparing single bilayered liposomes
US4783450A (en) * 1987-04-13 1988-11-08 Warner-Lambert Company Use of commercial lecithin as skin penetration enhancer
EP0382777B1 (en) * 1987-10-19 1994-10-12 The Liposome Company, Inc. Aqueous preparation of liposome composition
US5169846A (en) * 1989-10-12 1992-12-08 Crooks Michael J Non-aqueous micellar solutions of anthelmintic benzimidazoles, closantel, or phenothiazine, and insect growth regulators

Also Published As

Publication number Publication date
MY131524A (en) 2007-08-30
AU661754B2 (en) 1995-08-03
JPH07503953A (ja) 1995-04-27
WO1993015719A1 (en) 1993-08-19
AU3453593A (en) 1993-09-03
ES2091019T3 (es) 1996-10-16
IL104689A0 (en) 1993-06-10
EP0625899A1 (en) 1994-11-30
DE69302897D1 (de) 1996-07-04
ZA93955B (en) 1994-08-11
DE69302897T2 (de) 1996-09-26
IL104689A (en) 1996-12-05
CA2129828A1 (en) 1993-08-19
TW267103B (da) 1996-01-01
EP0625899B1 (en) 1996-05-29
KR940703651A (ko) 1994-12-12
ATE138561T1 (de) 1996-06-15
CN1076614A (zh) 1993-09-29
MX9300708A (es) 1994-07-29
GR3020695T3 (en) 1996-10-31

Similar Documents

Publication Publication Date Title
DK0625899T3 (da) Liposom-itraconazolformuleringer
EP0727982A4 (en) PROPYLENE GLYCOL STEARATE VESICLE
ES2153385T3 (es) Composicion acuosa a base de hormona del crecimiento humana.
PT758248E (pt) Formulacoes para o factor ix
DK0580817T3 (da) Farmaceutisk præparat og fremgangsmåde til fremstilling deraf
NO910340L (no) Topiske preparater for behandling av menneskenegler.
ATE321534T1 (de) Verbesserte liposomale formulierung
AU674142B2 (en) Use of cosmetic composition
FI934913A7 (fi) Liposomaalisia prostaglandiiniformulaatioita
DK0625898T3 (da) Liposom-piroxicamformuleringer
DE69005410D1 (de) Verfahren zur Herstellung einer wässrigen Dispersion von Lipidvesikeln sowie Zusammensetzung auf Basis der so hergestellten Dispersion.
IT1119948B (it) Tensioattivi cationici particolarmente per cosmetici e procedimento per la loro preparazione
IT8841613A0 (it) Stazione di lavoro particolarmente per l'esecuzione di preparati gastronomici.
DE59205958D1 (de) Dose für Kosmetikzubereitungen
NO178286C (no) Fremgangsmåte ved fremstilling av et topisk farmasöytisk preparat inneholdende 1
EP0603405A4 (en) COMPOSITION FOR TREATING ACNE VULGARIN.
IT1255762B (it) Formulazioni liposomiche di piroxicam.
FI951092A7 (fi) Fluoreseiinijohdannaisten stabiilit korkeakonsentroidut valmisteet
ES2073286T3 (es) Productos cosmeticos estables.
NO961429D0 (no) Fremgangsmåte for fremstilling av kinolonholdige, orale preparater
NO178782C (no) Fremgangsmåte for fremstilling av et farmasöytisk akseptabelt gelpreparat
ES2088682T3 (es) Agente bronceador de la piel.
NO169071C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-fenyl-3-(1h-1,2,4-triazol-1-ylmetyl)-5-substituerte-2-metylisoxazolidiner
TH13522A (th) การเข้าสูตรไลโพโซมับ อิทราโคนาโซล
IT8225072A0 (it) Composizioni a base di estratto di mirtillo per uso terapeutico e processo per la loro preparazione.